🎗️ OncologyInjection (IV)
Pluvicto
Lutetium Lu 177 Vipivotide Tetraxetan
PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer.
Form
Injection (IV)
Uses
2
Side effects
5
Category
Oncology
01
What is Pluvicto used for?
- Metastatic castration-resistant prostate cancer (mCRPC)
- PSMA-positive prostate cancer
02
Lutetium Lu 177 Vipivotide Tetraxetan side effects
The following side effects have been reported for Lutetium Lu 177 Vipivotide Tetraxetan. Their order does not indicate how often an effect occurs.
Fatigue
Nausea
Dry mouth
Bone marrow suppression
Renal toxicity
03
Lutetium Lu 177 Vipivotide Tetraxetan warnings & precautions
- Myelosuppression. Monitor CBC
- Embryo-fetal toxicity
- Radiation safety precautions required
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Pluvicto in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.